• LOOK AT THE AVICENNA ALLIANCE LATEST PUBLICATIONS

    The Avicenna Alliance continuously releases statements, opinions and feedback towards policy makers and regulators.

    FIND OUT MORE

  • Avicenna Alliance continues to grow. The Avicenna Alliance is proud to announce the newest additions to its list of members.

     

    FIND OUT MORE

  • THE AVICENNA ALLIANCE  
    ORGANISES MONTHLY MEMBERS WEBINARS

    Monthly webinars for Avicenna Members are organised to enable both companies' members and VPH Institute members to better and share their knowledge about their main activities and expertise in therapeutic areas for in silico medicine!

    Become member of the Avicenna Alliance and access our webinars recordings and upcoming presentations!

    Become a member

Survey Report - A snapshot of current practices and perceptions of Public & Patient Involvement (PPI) within the Avicenna Alliance 

Recognizing the vital role of public and patient involvement (PPI)...

find out more ›

Welcome to our new member MDsim!

We are delighted to welcome our new member MDsim!

MDsim is a health-tech start-up, based in Luxembourg, active in the In-Silico Medicine. 

find out more ›

Mapping the use of computational modelling and simulation in clinics: A survey

Computational modelling and simulation (CM&S) can be used in medicine to mimic biological processes with the goal of...

find out more ›

Nathalie Virag is the new Avicenna International Affairs Working Group Leader!

Nathalie Virag, Ph.D is a Distinguished Scientist at Medtronic Corporate Technology & Innovation. She has more than 25...

find out more ›

Second release of Avicenna Glossary now available!

This Glossary is a second release with an extended list of definitions; more concepts will be defined and existing definitions may be adjusted in...

find out more ›

We are delighted to welcome France Biotech as a new Avicenna Partner

Founded in 1997, France Biotech is an independent association, uniting the country’s leading innovative health companies and their...

find out more ›

The potential of in silico approaches to streamline drug development

This position paper highlights the potential of in silico medicine, using computational modelling and simulation to aid drug...

find out more ›

Page 1 of 29.

Sign up for our monthly newsletter!


Sign up